Targeting circDGKD Intercepts TKI’s Effects on Up-Regulation of Estrogen Receptor β and Vasculogenic Mimicry in Renal Cell Carcinoma
Vasculogenic mimicry (VM) has been reported as an alternative channel to increase tumor nutrient supplies and accelerate tumor progression, and is associated with poor survival prognosis in multiple cancers, including renal cell carcinoma (RCC). The currently used anti-angiogenic treatment for metas...
Main Authors: | Jie Ding, Xin-Gang Cui, Hao-Jie Chen, Yin Sun, Wei-Wei Yu, Jie Luo, Guang-Qian Xiao, Chawnshang Chang, Jun Qi, Shuyuan Yeh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/7/1639 |
Similar Items
-
Vasculogenic mimicry persists during glioblastoma xenograft growth
by: Cong Li, et al.
Published: (2018-01-01) -
Therapeutic potential of vasculogenic mimicry in urological tumors
by: Xinyu Lin, et al.
Published: (2023-09-01) -
Sp1 Plays a Key Role in Vasculogenic Mimicry of Human Prostate Cancer Cells
by: Deok-Soo Han, et al.
Published: (2022-01-01) -
Editorial: Neovascularization, Angiogenesis and Vasculogenic Mimicry in Cancer
by: César López-Camarillo, et al.
Published: (2020-07-01) -
Vasculogenic mimicry in carcinogenesis and clinical applications
by: Qingxi Luo, et al.
Published: (2020-03-01)